We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · July 29, 2020

Second-Look Surgery Plus Hyperthermic Intraperitoneal Chemotherapy vs Surveillance in Patients at High Risk of Developing Colorectal Peritoneal Metastases

The Lancet Oncology

 

Additional Info

The Lancet Oncology
Second-Look Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Versus Surveillance in Patients at High Risk of Developing Colorectal Peritoneal Metastases (PROPHYLOCHIP-PRODIGE 15): A Randomised, Phase 3 Study
Lancet Oncol 2020 Jul 24;[EPub Ahead of Print], D Goéré, O Glehen, F Quenet, JM Guilloit, JM Bereder, G Lorimier, E Thibaudeau, L Ghouti, A Pinto, JJ Tuech, R Kianmanesh, M Carretier, F Marchal, C Arvieux, C Brigand, P Meeus, P Rat, S Durand-Fontanier, P Mariani, Z Lakkis, V Loi, N Pirro, C Sabbagh, M Texier, D Elias

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading